Previous analysis of the membrane proteome of renal cancer cells fractionated from a post-nuclear supernatant using a 60% sucrose cushion followed by a 15–60% sucrose gradient identified high expression of CD70 and showed that this protein could act as a target in antibody-targeted cytotoxic therapy (27). The gene discussed is CD70; the disease is renal carcinoma.